Global Interventional Oncology Devices Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
Page: 113
Published Date: 19 Nov 2021
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The Interventional Oncology Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Interventional Oncology Devices size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Interventional Oncology Devices market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Interventional Oncology Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ablation Equipment
Embolization Device
Catheter Device
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Interventional Oncology Devices market are listed below:
AngioDynamics
BD
Boston Scientific
Eckert & Ziegler BEBIG GmbH
HealthTronics
IceCure Medical Ltd
Johnson & Johnson
Medtronic
Merit Medical Systems
Sanarus Technologies
Sonablate Corp
Terumo Corporation
Trod Medical
Varian Medical Systems
Abbott Laboratories
Cook Medical
MicroPort Group
LifeTech Scientific
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Interventional Oncology Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Interventional Oncology Devices, with price, sales, revenue and global market share of Interventional Oncology Devices from 2019 to 2021.
Chapter 3, the Interventional Oncology Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Interventional Oncology Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Interventional Oncology Devices market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Interventional Oncology Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Interventional Oncology Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Interventional Oncology Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Ablation Equipment
1.2.3 Embolization Device
1.2.4 Catheter Device
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Interventional Oncology Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Interventional Oncology Devices Market Size & Forecast
1.4.1 Global Interventional Oncology Devices Sales in Value (2016-2026))
1.4.2 Global Interventional Oncology Devices Sales in Volume (2016-2026)
1.4.3 Global Interventional Oncology Devices Price by Type (2016-2026) & (US$/Unit)
1.5 Global Interventional Oncology Devices Production Capacity Analysis
1.5.1 Global Interventional Oncology Devices Total Production Capacity (2016-2026)
1.5.2 Global Interventional Oncology Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Interventional Oncology Devices Market Drivers
1.6.2 Interventional Oncology Devices Market Restraints
1.6.3 Interventional Oncology Devices Trends Analysis
2 Manufacturers Profiles
2.1 AngioDynamics
2.1.1 AngioDynamics Details
2.1.2 AngioDynamics Major Business
2.1.3 AngioDynamics Interventional Oncology Devices Product and Services
2.1.4 AngioDynamics Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 BD
2.2.1 BD Details
2.2.2 BD Major Business
2.2.3 BD Interventional Oncology Devices Product and Services
2.2.4 BD Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Interventional Oncology Devices Product and Services
2.3.4 Boston Scientific Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eckert & Ziegler BEBIG GmbH
2.4.1 Eckert & Ziegler BEBIG GmbH Details
2.4.2 Eckert & Ziegler BEBIG GmbH Major Business
2.4.3 Eckert & Ziegler BEBIG GmbH Interventional Oncology Devices Product and Services
2.4.4 Eckert & Ziegler BEBIG GmbH Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 HealthTronics
2.5.1 HealthTronics Details
2.5.2 HealthTronics Major Business
2.5.3 HealthTronics Interventional Oncology Devices Product and Services
2.5.4 HealthTronics Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 IceCure Medical Ltd
2.6.1 IceCure Medical Ltd Details
2.6.2 IceCure Medical Ltd Major Business
2.6.3 IceCure Medical Ltd Interventional Oncology Devices Product and Services
2.6.4 IceCure Medical Ltd Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Interventional Oncology Devices Product and Services
2.7.4 Johnson & Johnson Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Medtronic
2.8.1 Medtronic Details
2.8.2 Medtronic Major Business
2.8.3 Medtronic Interventional Oncology Devices Product and Services
2.8.4 Medtronic Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Merit Medical Systems
2.9.1 Merit Medical Systems Details
2.9.2 Merit Medical Systems Major Business
2.9.3 Merit Medical Systems Interventional Oncology Devices Product and Services
2.9.4 Merit Medical Systems Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Sanarus Technologies
2.10.1 Sanarus Technologies Details
2.10.2 Sanarus Technologies Major Business
2.10.3 Sanarus Technologies Interventional Oncology Devices Product and Services
2.10.4 Sanarus Technologies Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Sonablate Corp
2.11.1 Sonablate Corp Details
2.11.2 Sonablate Corp Major Business
2.11.3 Sonablate Corp Interventional Oncology Devices Product and Services
2.11.4 Sonablate Corp Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Terumo Corporation
2.12.1 Terumo Corporation Details
2.12.2 Terumo Corporation Major Business
2.12.3 Terumo Corporation Interventional Oncology Devices Product and Services
2.12.4 Terumo Corporation Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Trod Medical
2.13.1 Trod Medical Details
2.13.2 Trod Medical Major Business
2.13.3 Trod Medical Interventional Oncology Devices Product and Services
2.13.4 Trod Medical Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Varian Medical Systems
2.14.1 Varian Medical Systems Details
2.14.2 Varian Medical Systems Major Business
2.14.3 Varian Medical Systems Interventional Oncology Devices Product and Services
2.14.4 Varian Medical Systems Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Abbott Laboratories
2.15.1 Abbott Laboratories Details
2.15.2 Abbott Laboratories Major Business
2.15.3 Abbott Laboratories Interventional Oncology Devices Product and Services
2.15.4 Abbott Laboratories Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Cook Medical
2.16.1 Cook Medical Details
2.16.2 Cook Medical Major Business
2.16.3 Cook Medical Interventional Oncology Devices Product and Services
2.16.4 Cook Medical Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 MicroPort Group
2.17.1 MicroPort Group Details
2.17.2 MicroPort Group Major Business
2.17.3 MicroPort Group Interventional Oncology Devices Product and Services
2.17.4 MicroPort Group Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 LifeTech Scientific
2.18.1 LifeTech Scientific Details
2.18.2 LifeTech Scientific Major Business
2.18.3 LifeTech Scientific Interventional Oncology Devices Product and Services
2.18.4 LifeTech Scientific Interventional Oncology Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Interventional Oncology Devices Sales by Manufacturer
3.1 Global Interventional Oncology Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Interventional Oncology Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Interventional Oncology Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Interventional Oncology Devices Manufacturer Market Share
3.4.2 Top 6 Interventional Oncology Devices Manufacturer Market Share
3.5 Global Interventional Oncology Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Interventional Oncology Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Interventional Oncology Devices Market Size by Region
4.1.1 Global Interventional Oncology Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Interventional Oncology Devices Revenue by Region (2016-2026)
4.2 North America Interventional Oncology Devices Revenue (2016-2026)
4.3 Europe Interventional Oncology Devices Revenue (2016-2026)
4.4 Asia-Pacific Interventional Oncology Devices Revenue (2016-2026)
4.5 South America Interventional Oncology Devices Revenue (2016-2026)
4.6 Middle East and Africa Interventional Oncology Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Interventional Oncology Devices Sales in Volume by Type (2016-2026)
5.2 Global Interventional Oncology Devices Revenue by Type (2016-2026)
5.3 Global Interventional Oncology Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Interventional Oncology Devices Sales in Volume by Application (2016-2026)
6.2 Global Interventional Oncology Devices Revenue by Application (2016-2026)
6.3 Global Interventional Oncology Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Interventional Oncology Devices Sales by Type (2016-2026)
7.2 North America Interventional Oncology Devices Sales by Application (2016-2026)
7.3 North America Interventional Oncology Devices Market Size by Country
7.3.1 North America Interventional Oncology Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Interventional Oncology Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Interventional Oncology Devices Sales by Type (2016-2026)
8.2 Europe Interventional Oncology Devices Sales by Application (2016-2026)
8.3 Europe Interventional Oncology Devices Market Size by Country
8.3.1 Europe Interventional Oncology Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Interventional Oncology Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Interventional Oncology Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Interventional Oncology Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Interventional Oncology Devices Market Size by Region
9.3.1 Asia-Pacific Interventional Oncology Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Interventional Oncology Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Interventional Oncology Devices Sales by Type (2016-2026)
10.2 South America Interventional Oncology Devices Sales by Application (2016-2026)
10.3 South America Interventional Oncology Devices Market Size by Country
10.3.1 South America Interventional Oncology Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Interventional Oncology Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Interventional Oncology Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Interventional Oncology Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Interventional Oncology Devices Market Size by Country
11.3.1 Middle East & Africa Interventional Oncology Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Interventional Oncology Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Interventional Oncology Devices Typical Distributors
12.3 Interventional Oncology Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Interventional Oncology Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Interventional Oncology Devices Revenue by Application, (USD Million), 2021-2026
Table 3. AngioDynamics Basic Information, Manufacturing Base and Competitors
Table 4. AngioDynamics Major Business
Table 5. AngioDynamics Interventional Oncology Devices Product and Services
Table 6. AngioDynamics Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BD Basic Information, Manufacturing Base and Competitors
Table 8. BD Major Business
Table 9. BD Interventional Oncology Devices Product and Services
Table 10. BD Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 12. Boston Scientific Major Business
Table 13. Boston Scientific Interventional Oncology Devices Product and Services
Table 14. Boston Scientific Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eckert & Ziegler BEBIG GmbH Basic Information, Manufacturing Base and Competitors
Table 16. Eckert & Ziegler BEBIG GmbH Major Business
Table 17. Eckert & Ziegler BEBIG GmbH Interventional Oncology Devices Product and Services
Table 18. Eckert & Ziegler BEBIG GmbH Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. HealthTronics Basic Information, Manufacturing Base and Competitors
Table 20. HealthTronics Major Business
Table 21. HealthTronics Interventional Oncology Devices Product and Services
Table 22. HealthTronics Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. IceCure Medical Ltd Basic Information, Manufacturing Base and Competitors
Table 24. IceCure Medical Ltd Major Business
Table 25. IceCure Medical Ltd Interventional Oncology Devices Product and Services
Table 26. IceCure Medical Ltd Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson & Johnson Major Business
Table 29. Johnson & Johnson Interventional Oncology Devices Product and Services
Table 30. Johnson & Johnson Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Medtronic Basic Information, Manufacturing Base and Competitors
Table 32. Medtronic Major Business
Table 33. Medtronic Interventional Oncology Devices Product and Services
Table 34. Medtronic Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Merit Medical Systems Basic Information, Manufacturing Base and Competitors
Table 36. Merit Medical Systems Major Business
Table 37. Merit Medical Systems Interventional Oncology Devices Product and Services
Table 38. Merit Medical Systems Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Sanarus Technologies Basic Information, Manufacturing Base and Competitors
Table 40. Sanarus Technologies Major Business
Table 41. Sanarus Technologies Interventional Oncology Devices Product and Services
Table 42. Sanarus Technologies Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sonablate Corp Basic Information, Manufacturing Base and Competitors
Table 44. Sonablate Corp Major Business
Table 45. Sonablate Corp Interventional Oncology Devices Product and Services
Table 46. Sonablate Corp Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table 48. Terumo Corporation Major Business
Table 49. Terumo Corporation Interventional Oncology Devices Product and Services
Table 50. Terumo Corporation Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Trod Medical Basic Information, Manufacturing Base and Competitors
Table 52. Trod Medical Major Business
Table 53. Trod Medical Interventional Oncology Devices Product and Services
Table 54. Trod Medical Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Varian Medical Systems Basic Information, Manufacturing Base and Competitors
Table 56. Varian Medical Systems Major Business
Table 57. Varian Medical Systems Interventional Oncology Devices Product and Services
Table 58. Varian Medical Systems Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Abbott Laboratories Major Business
Table 61. Abbott Laboratories Interventional Oncology Devices Product and Services
Table 62. Abbott Laboratories Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Cook Medical Basic Information, Manufacturing Base and Competitors
Table 64. Cook Medical Major Business
Table 65. Cook Medical Interventional Oncology Devices Product and Services
Table 66. Cook Medical Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. MicroPort Group Basic Information, Manufacturing Base and Competitors
Table 68. MicroPort Group Major Business
Table 69. MicroPort Group Interventional Oncology Devices Product and Services
Table 70. MicroPort Group Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. LifeTech Scientific Basic Information, Manufacturing Base and Competitors
Table 72. LifeTech Scientific Major Business
Table 73. LifeTech Scientific Interventional Oncology Devices Product and Services
Table 74. LifeTech Scientific Interventional Oncology Devices Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Global Interventional Oncology Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 76. Global Interventional Oncology Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 77. Market Position of Manufacturers in Interventional Oncology Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 78. Global Interventional Oncology Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 79. Head Office and Interventional Oncology Devices Production Site of Key Manufacturer
Table 80. Interventional Oncology Devices New Entrant and Capacity Expansion Plans
Table 81. Interventional Oncology Devices Mergers & Acquisitions in the Past Five Years
Table 82. Global Interventional Oncology Devices Sales by Region (2016-2021e) & (K Units)
Table 83. Global Interventional Oncology Devices Sales by Region (2021-2026) & (K Units)
Table 84. Global Interventional Oncology Devices Revenue by Region (2016-2021e) & (USD Million)
Table 85. Global Interventional Oncology Devices Revenue by Region (2021-2026) & (USD Million)
Table 86. Global Interventional Oncology Devices Sales by Type (2016-2021e) & (K Units)
Table 87. Global Interventional Oncology Devices Sales by Type (2021-2026) & (K Units)
Table 88. Global Interventional Oncology Devices Revenue by Type (2016-2021e) & (USD Million)
Table 89. Global Interventional Oncology Devices Revenue by Type (2021-2026) & (USD Million)
Table 90. Global Interventional Oncology Devices Price by Type (2016-2021e) & (US$/Unit)
Table 91. Global Interventional Oncology Devices Price by Type (2021-2026) & (US$/Unit)
Table 92. Global Interventional Oncology Devices Sales by Application (2016-2021e) & (K Units)
Table 93. Global Interventional Oncology Devices Sales by Application (2021-2026) & (K Units)
Table 94. Global Interventional Oncology Devices Revenue by Application (2016-2021e) & (USD Million)
Table 95. Global Interventional Oncology Devices Revenue by Application (2021-2026) & (USD Million)
Table 96. Global Interventional Oncology Devices Price by Application (2016-2021e) & (US$/Unit)
Table 97. Global Interventional Oncology Devices Price by Application (2021-2026) & (US$/Unit)
Table 98. North America Interventional Oncology Devices Sales by Country (2016-2021e) & (K Units)
Table 99. North America Interventional Oncology Devices Sales by Country (2021-2026) & (K Units)
Table 100. North America Interventional Oncology Devices Revenue by Country (2016-2021e) & (USD Million)
Table 101. North America Interventional Oncology Devices Revenue by Country (2021-2026) & (USD Million)
Table 102. North America Interventional Oncology Devices Sales by Type (2016-2021e) & (K Units)
Table 103. North America Interventional Oncology Devices Sales by Type (2021-2026) & (K Units)
Table 104. North America Interventional Oncology Devices Sales by Application (2016-2021e) & (K Units)
Table 105. North America Interventional Oncology Devices Sales by Application (2021-2026) & (K Units)
Table 106. Europe Interventional Oncology Devices Sales by Country (2016-2021e) & (K Units)
Table 107. Europe Interventional Oncology Devices Sales by Country (2021-2026) & (K Units)
Table 108. Europe Interventional Oncology Devices Revenue by Country (2016-2021e) & (USD Million)
Table 109. Europe Interventional Oncology Devices Revenue by Country (2021-2026) & (USD Million)
Table 110. Europe Interventional Oncology Devices Sales by Type (2016-2021e) & (K Units)
Table 111. Europe Interventional Oncology Devices Sales by Type (2021-2026) & (K Units)
Table 112. Europe Interventional Oncology Devices Sales by Application (2016-2021e) & (K Units)
Table 113. Europe Interventional Oncology Devices Sales by Application (2021-2026) & (K Units)
Table 114. Asia-Pacific Interventional Oncology Devices Sales by Region (2016-2021e) & (K Units)
Table 115. Asia-Pacific Interventional Oncology Devices Sales by Region (2021-2026) & (K Units)
Table 116. Asia-Pacific Interventional Oncology Devices Revenue by Region (2016-2021e) & (USD Million)
Table 117. Asia-Pacific Interventional Oncology Devices Revenue by Region (2021-2026) & (USD Million)
Table 118. Asia-Pacific Interventional Oncology Devices Sales by Type (2016-2021e) & (K Units)
Table 119. Asia-Pacific Interventional Oncology Devices Sales by Type (2021-2026) & (K Units)
Table 120. Asia-Pacific Interventional Oncology Devices Sales by Application (2016-2021e) & (K Units)
Table 121. Asia-Pacific Interventional Oncology Devices Sales by Application (2021-2026) & (K Units)
Table 122. South America Interventional Oncology Devices Sales by Country (2016-2021e) & (K Units)
Table 123. South America Interventional Oncology Devices Sales by Country (2021-2026) & (K Units)
Table 124. South America Interventional Oncology Devices Revenue by Country (2016-2021e) & (USD Million)
Table 125. South America Interventional Oncology Devices Revenue by Country (2021-2026) & (USD Million)
Table 126. South America Interventional Oncology Devices Sales by Type (2016-2021e) & (K Units)
Table 127. South America Interventional Oncology Devices Sales by Type (2021-2026) & (K Units)
Table 128. South America Interventional Oncology Devices Sales by Application (2016-2021e) & (K Units)
Table 129. South America Interventional Oncology Devices Sales by Application (2021-2026) & (K Units)
Table 130. Middle East & Africa Interventional Oncology Devices Sales by Country (2016-2021e) & (K Units)
Table 131. Middle East & Africa Interventional Oncology Devices Sales by Country (2021-2026) & (K Units)
Table 132. Middle East & Africa Interventional Oncology Devices Revenue by Country (2016-2021e) & (USD Million)
Table 133. Middle East & Africa Interventional Oncology Devices Revenue by Country (2021-2026) & (USD Million)
Table 134. Middle East & Africa Interventional Oncology Devices Sales by Type (2016-2021e) & (K Units)
Table 135. Middle East & Africa Interventional Oncology Devices Sales by Type (2021-2026) & (K Units)
Table 136. Middle East & Africa Interventional Oncology Devices Sales by Application (2016-2021e) & (K Units)
Table 137. Middle East & Africa Interventional Oncology Devices Sales by Application (2021-2026) & (K Units)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Interventional Oncology Devices Typical Distributors
Table 141. Interventional Oncology Devices Typical Customers
List of Figures
Figure 1. Interventional Oncology Devices Picture
Figure 2. Global Interventional Oncology Devices Sales Market Share by Type in 2020
Figure 3. Ablation Equipment
Figure 4. Embolization Device
Figure 5. Catheter Device
Figure 6. Others
Figure 7. Global Interventional Oncology Devices Sales Market Share by Application in 2020
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Interventional Oncology Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Interventional Oncology Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Interventional Oncology Devices Sales (2016-2026) & (K Units)
Figure 14. Global Interventional Oncology Devices Price by Type (2016-2026) & (US$/Unit)
Figure 15. Global Interventional Oncology Devices Production Capacity (2016-2026) & (K Units)
Figure 16. Global Interventional Oncology Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Interventional Oncology Devices Market Drivers
Figure 18. Interventional Oncology Devices Market Restraints
Figure 19. Interventional Oncology Devices Market Trends
Figure 20. Global Interventional Oncology Devices Sales Market Share by Manufacturer in 2020
Figure 21. Global Interventional Oncology Devices Revenue Market Share by Manufacturer in 2020
Figure 22. Interventional Oncology Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Interventional Oncology Devices Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Interventional Oncology Devices Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Interventional Oncology Devices Sales Market Share by Region (2016-2026)
Figure 26. Global Interventional Oncology Devices Revenue Market Share by Region (2016-2026)
Figure 27. North America Interventional Oncology Devices Revenue (2016-2026) & (USD Million)
Figure 28. Europe Interventional Oncology Devices Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Interventional Oncology Devices Revenue (2016-2026) & (USD Million)
Figure 30. South America Interventional Oncology Devices Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Interventional Oncology Devices Revenue (2016-2026) & (USD Million)
Figure 32. Global Interventional Oncology Devices Sales Market Share by Type (2016-2026)
Figure 33. Global Interventional Oncology Devices Revenue Market Share by Type (2016-2026)
Figure 34. Global Interventional Oncology Devices Price by Type (2016-2026) & (US$/Unit)
Figure 35. Global Interventional Oncology Devices Sales Market Share by Application (2016-2026)
Figure 36. Global Interventional Oncology Devices Revenue Market Share by Application (2016-2026)
Figure 37. Global Interventional Oncology Devices Price by Application (2016-2026) & (US$/Unit)
Figure 38. North America Interventional Oncology Devices Sales Market Share by Type (2016-2026)
Figure 39. North America Interventional Oncology Devices Sales Market Share by Application (2016-2026)
Figure 40. North America Interventional Oncology Devices Sales Market Share by Country (2016-2026)
Figure 41. North America Interventional Oncology Devices Revenue Market Share by Country (2016-2026)
Figure 42. United States Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Interventional Oncology Devices Sales Market Share by Type (2016-2026)
Figure 46. Europe Interventional Oncology Devices Sales Market Share by Application (2016-2026)
Figure 47. Europe Interventional Oncology Devices Sales Market Share by Country (2016-2026)
Figure 48. Europe Interventional Oncology Devices Revenue Market Share by Country (2016-2026)
Figure 49. Germany Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Interventional Oncology Devices Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Interventional Oncology Devices Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Interventional Oncology Devices Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Interventional Oncology Devices Revenue Market Share by Region (2016-2026)
Figure 58. China Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Interventional Oncology Devices Sales Market Share by Type (2016-2026)
Figure 65. South America Interventional Oncology Devices Sales Market Share by Application (2016-2026)
Figure 66. South America Interventional Oncology Devices Sales Market Share by Country (2016-2026)
Figure 67. South America Interventional Oncology Devices Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Interventional Oncology Devices Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Interventional Oncology Devices Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Interventional Oncology Devices Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Interventional Oncology Devices Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Interventional Oncology Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
AngioDynamics BD Boston Scientific Eckert & Ziegler BEBIG GmbH HealthTronics IceCure Medical Ltd Johnson & Johnson Medtronic Merit Medical Systems Sanarus Technologies Sonablate Corp Terumo Corporation Trod Medical Varian Medical Systems Abbott Laboratories Cook Medical MicroPort Group LifeTech Scientific
Related Reports
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>